Hemarsh Technologies was established in 2008 and focuses on contract research and impurity synthesis for pharmaceutical companies. The document provides information on various saxagliptin isomer and 3-deoxy impurities produced by Hemarsh Technologies, including CAS numbers and molecular formulas. Contact information is provided at the bottom for any questions.